PEBP1

Phosphatidylethanolamine-binding protein 1 · P30086 · PEBP1 on Sugi Atlas →

600 patent compounds predicted against PEBP1, 526 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
Tivozanib (SCHEMBL172883)	1.00	1/20
Tivozanib (SCHEMBL29354238)	1.00	1/20
Tivozanib (SCHEMBL29354604)	1.00	1/20
Tivozanib (SCHEMBL1869882)	0.98	1/20
Tivozanib (SCHEMBL30993908)	0.98	1/20
Tivozanib (SCHEMBL21174286)	0.97	1/20
Tivozanib (SCHEMBL29394095)	0.97	1/20
Tivozanib (SCHEMBL5209537)	0.93	1/20
Tivozanib (SCHEMBL5214691)	0.93	1/20
Tivozanib (SCHEMBL5211590)	0.90	1/20
Tivozanib (SCHEMBL5213723)	0.90	1/20
Tivozanib (SCHEMBL5545131)	0.90	1/20
SCHEMBL14409673	0.89	1/20
SCHEMBL15962810	0.89	1/20
Tivozanib (SCHEMBL27218324)	0.89	1/20
SCHEMBL15962809	0.88	1/20
SCHEMBL15962834	0.88	1/20
SCHEMBL31452948	0.86	1/20
Tivozanib (SCHEMBL5214257)	0.84	1/20
SCHEMBL19645596	0.84	1/20

Clinical trials — most relevant to PEBP1 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer	PHASE2	COMPLETED
NEO100 and High-Grade Meningioma	PHASE2	RECRUITING
Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides	PHASE1	COMPLETED
the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease.	nan	UNKNOWN
Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in Children	nan	WITHDRAWN
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)	nan	COMPLETED
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2	nan	UNKNOWN
Autophagy in Systemic Lupus Erythematosus	nan	UNKNOWN
Investigation of Secreted Phosphoproteins and PiP3 (Phosphoinositolphospat 3) in Sputum	nan	COMPLETED
Young Pectus Excavatum Patients and Genetic Defects	nan	COMPLETED
Choline to Improve Malnutrition and Enhance Cognition	nan	RECRUITING
Study of the Pathophysiological Mechanisms Involved in Bleeding Events	nan	COMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH)	nan	COMPLETED
Immune Cell Response to Stimuli	nan	RECRUITING
PCD New Gene Discovery	nan	COMPLETED
Composition & Function of Sarcoplasmic Reticulum in Persons With the Metabolic Syndrome	nan	COMPLETED
Vitreous Proteomics of Patients Suffering From Pseudoexfoliation Syndrome	nan	ACTIVE_NOT_RECRUITING
Epidemiology of Atherosclerosis	nan	COMPLETED
Chest Wall Deformities in Children - Epidemiological Data	nan	COMPLETED
Predictive Value of Maternal Blood Protein Signatures in Preterm Birth	nan	COMPLETED
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease	nan	RECRUITING
Surfactant Derived Protocol in Heart Failure	nan	COMPLETED
Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes	nan	COMPLETED
Inflammatory Genomics in Human Carotid Artery Disease	nan	COMPLETED
Autophagy Bladder Cancer	nan	UNKNOWN
Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study	nan	COMPLETED
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases	nan	UNKNOWN
Unraveling Genetics of HypoPhosPhatasia (HPP Genetics)	nan	COMPLETED
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas	nan	RECRUITING
Familial Partial Lipodystrophy Study	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a PEBP1 binder may also engage these)

Protein	Name	Similarity
Q5R4R0	—	1.000	Q5R4R0 →
Q3YIX4	—	1.000	Q3YIX4 →
Q8MK67	—	1.000	Q8MK67 →
P31044	—	1.000	P31044 →
P13696	—	0.998	P13696 →
P48737	—	0.998	P48737 →
O16264	—	0.993	O16264 →
P70296	—	0.992	P70296 →
Q656A5	—	0.990	Q656A5 →
Q06252	—	0.990	Q06252 →
P14306	—	0.987	P14306 →
Q93WI9	—	0.986	Q93WI9 →
Q41261	—	0.985	Q41261 →
P54186	—	0.985	P54186 →
Q9XFK7	—	0.985	Q9XFK7 →
Q9XH44	—	0.982	Q9XH44 →
P54188	—	0.981	P54188 →
Q9FIT4	—	0.981	Q9FIT4 →
P31729	—	0.980	P31729 →
A0A286R227	—	0.980	A0A286R227 →
P93028	—	0.979	P93028 →
P14882	—	0.979	P14882 →
Q7SIA2	—	0.979	Q7SIA2 →
Q38970	—	0.979	Q38970 →
Q9C566	—	0.979	Q9C566 →
P93834	—	0.979	P93834 →
Q21693	—	0.978	Q21693 →
P14946	—	0.978	P14946 →
O14224	—	0.978	O14224 →
P83753	—	0.978	P83753 →